Article
Interaction of avilamycin with ribosomes and resistance caused by mutations in 23S rRNA.
Antimicrobial agents and chemotherapy - 1 Nov 2002
Kofoed Christine B, Vester Birte
Abstract excerpt
The antibiotic growth promoter avilamycin inhibits protein synthesis by binding to bacterial ribosomes. Here the binding site is further characterized on Escherichia coli ribosomes. The drug interacts with domain V of 23S rRNA, giving a chemical footprint at nucleotides A2482 and A2534. Selection of avilamycin-resistant Halobacterium halobium cells revealed mutations in helix 89 of 23S rRNA. Furthermore,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
